For the purpose of this study, in order to detect true active infections and eliminate false reactive results inherent to the technology used [8,9], and based on the detection of viral RNA or DNA, repeatedly reactive samples—both in serological screening and NAT, plus detected window periods—were considered to be confirmed-positive reactive results. This evidence concerns the gene BRD2 and infection.